Skip to main content
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.06
-0.46 (-1.67%)
At close: Apr 28, 2026, 4:00 PM EDT
27.00
-0.06 (-0.22%)
After-hours: Apr 28, 2026, 4:00 PM EDT

Assembly Biosciences Revenue

In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth. Assembly Biosciences had revenue of $42.47M in the quarter ending December 31, 2025, with 477.26% growth.

Revenue (ttm)
$72.30M
Revenue Growth
+153.52%
P/S Ratio
5.91
Revenue / Employee
$990,452
Employees
73
Market Cap
429.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 170.44M
Ginkgo Bioworks Holdings 170.16M
XOMA Royalty 52.15M
Entrada Therapeutics 25.42M
Neurogene 925.00K
Revenue Rankings

ASMB News

More News